Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular Carcinoma

Fig. 3

High expression of ZBTB9 indicated poor survival in patients with LIHC. OS analysis in LIHC (A), DSS analysis in LIHC (B), and OS analysis with 79 samples (C). The forest plot showed the ZBTB9 hazard rate in different cancers (D). Diagnostic ROC analysis with the AUC of ZBTB9 in LIHC (E) (*p < 0.05; **p < 0.01; ***p < 0.001)

Back to article page